Update: 10.06.2025
Last week: 22 week 2025 (26.05.2025 - 01.06.2025)
Last full month: May 2025
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 8 939 | -7.3% | 13.0% | -0.6 | 20 406 863 | -7.9% | 9.8% | -0.5 | -2.8% |
| MoM | 40 295 | -3.4% | 13.1% | 0.5 | 92 162 664 | -1.7% | 9.9% | 0.5 | -7.3% |
| YTD | 201 864 | 27.1% | 12.8% | 1.7 | 442 157 146 | 25.1% | 9.5% | 0.1 | 10.0% |
| MAT | 464 514 | 26.1% | 13.0% | 2.9 | 927 812 621 | 20.2% | 9.4% | 0.8 | -2.3% |
| BRAINMAX | |||||||||
| WoW | 2 583 | 8.6% | 100.0% | 0 | 8 981 610 | 12.6% | 100.0% | 0 | 8.6% |
| MoM | 10 860 | -7.3% | 100.0% | 0 | 37 510 343 | -8.9% | 100.0% | 0 | -7.3% |
| YTD | 54 867 | 127.5% | 100.0% | 0 | 189 933 990 | 123.3% | 100.0% | 0 | 127.5% |
| MAT | 113 414 | 106.7% | 100.0% | 0 | 391 579 044 | 103.4% | 100.0% | 0 | 106.7% |
| GOLDLINE PLUS | |||||||||
| WoW | 15 815 | -5.2% | 45.6% | -0.1 | 49 561 551 | -6.7% | 36.6% | 0 | -5.0% |
| MoM | 73 279 | 0.6% | 45.7% | 0.3 | 231 834 163 | -0.9% | 36.9% | -0.5 | 0.1% |
| YTD | 360 898 | -4.5% | 45.7% | 1.2 | 1 162 165 827 | -2.9% | 37.4% | 1.1 | -7.1% |
| MAT | 812 048 | -5.8% | 46.0% | 0.6 | 2 567 829 759 | -5.6% | 37.7% | -0.6 | -6.9% |
| MIGRENIUM | |||||||||
| WoW | 7 329 | -6.2% | 0.3% | 0 | 2 584 375 | -6.5% | 0.5% | 0 | -0.9% |
| MoM | 34 787 | 1.5% | 0.4% | 0 | 12 297 924 | 1.5% | 0.5% | 0 | -2.5% |
| YTD | 179 470 | -32.8% | 0.4% | -0.2 | 62 980 432 | -21.4% | 0.5% | -0.2 | 5.8% |
| MAT | 480 065 | -25.4% | 0.4% | -0.1 | 164 545 205 | 6.2% | 0.5% | 0 | 0.7% |
| MODELAX-N | |||||||||
| WoW | 22 790 | -5.8% | 17.3% | -0.4 | 12 700 013 | -7.1% | 12.8% | -0.6 | -3.7% |
| MoM | 107 892 | -5.5% | 17.9% | -0.8 | 60 208 046 | -1.4% | 13.3% | -0.4 | -1.0% |
| YTD | 628 633 | -6.6% | 19.9% | -3.5 | 332 037 640 | 17.4% | 14.3% | -0.5 | 9.6% |
| MAT | 1 418 875 | 2.9% | 20.2% | -0.5 | 708 417 460 | 36.1% | 14.0% | 1.6 | 5.6% |
| REDUXIN | |||||||||
| WoW | 10 750 | -2.1% | 31.0% | 0.9 | 59 044 036 | -3.4% | 43.6% | 1.5 | -5.0% |
| MoM | 49 047 | -2.8% | 30.6% | -0.9 | 269 646 984 | -1.1% | 42.9% | -0.7 | 0.1% |
| YTD | 248 758 | -11.6% | 31.5% | -1.6 | 1 356 306 557 | -11.1% | 43.6% | -2.6 | -7.1% |
| MAT | 562 819 | -8.5% | 31.9% | -0.6 | 2 994 453 607 | -4.5% | 43.9% | -0.2 | -6.9% |
| REDUXIN FORTE | |||||||||
| WoW | 3 554 | -10.8% | 10.2% | -0.7 | 16 253 551 | -16.0% | 12.0% | -1.4 | -5.0% |
| MoM | 16 876 | 7.1% | 10.5% | 0.7 | 78 994 217 | 10.6% | 12.6% | 1.2 | 0.1% |
| YTD | 78 987 | 7.3% | 10.0% | 1.3 | 359 992 130 | 12.2% | 11.6% | 1.9 | -7.1% |
| MAT | 172 731 | 2.1% | 9.8% | 0.9 | 760 907 325 | 7.0% | 11.2% | 1.2 | -6.9% |
| SALVISAR | |||||||||
| WoW | 10 425 | -9.6% | 1.4% | -0.1 | 5 327 581 | -10.2% | 1.4% | -0.1 | -2.9% |
| MoM | 50 675 | -7.6% | 1.5% | -0.2 | 26 072 693 | -6.4% | 1.5% | -0.2 | 4.2% |
| YTD | 286 083 | 21.5% | 1.8% | 0.4 | 141 192 765 | 51.6% | 1.7% | 0.5 | -3.5% |
| MAT | 622 450 | 23.9% | 1.6% | 0.4 | 288 976 225 | 58.5% | 1.5% | 0.5 | -6.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 201 864 | 27.1% | 12.8% | 1.7 | 442 157 146 | 25.1% | 9.5% | 0.1 | 10.0% |
| BRAINMAX | 54 867 | 127.5% | 100.0% | 0 | 189 933 990 | 123.3% | 100.0% | 0 | 127.5% |
| GOLDLINE PLUS | 360 898 | -4.5% | 45.7% | 1.2 | 1 162 165 827 | -2.9% | 37.4% | 1.1 | -7.1% |
| MIGRENIUM | 179 470 | -32.8% | 0.4% | -0.2 | 62 980 432 | -21.4% | 0.5% | -0.2 | 5.8% |
| MODELAX-N | 628 633 | -6.6% | 19.9% | -3.5 | 332 037 640 | 17.4% | 14.3% | -0.5 | 9.6% |
| REDUXIN CAPS | 248 758 | -11.6% | 31.5% | -1.6 | 1 356 306 557 | -11.1% | 43.6% | -2.6 | -7.1% |
| REDUXIN FORTE | 78 987 | 7.3% | 10.0% | 1.3 | 359 992 130 | 12.2% | 11.6% | 1.9 | -7.1% |
| SALVISAR | 286 083 | 21.5% | 1.8% | 0.4 | 141 192 765 | 51.6% | 1.7% | 0.5 | -3.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 464 514 | 26.1% | 13.0% | 2.9 | 927 812 621 | 20.2% | 9.4% | 0.8 | -2.3% |
| BRAINMAX | 113 414 | 106.7% | 100.0% | 0 | 391 579 044 | 103.4% | 100.0% | 0 | 106.7% |
| GOLDLINE PLUS | 812 048 | -5.8% | 46.0% | 0.6 | 2 567 829 759 | -5.6% | 37.7% | -0.6 | -6.9% |
| MIGRENIUM | 480 065 | -25.4% | 0.4% | -0.1 | 164 545 205 | 6.2% | 0.5% | 0 | 0.7% |
| MODELAX-N | 1 418 875 | 2.9% | 20.2% | -0.5 | 708 417 460 | 36.1% | 14.0% | 1.6 | 5.6% |
| REDUXIN CAPS | 562 819 | -8.5% | 31.9% | -0.6 | 2 994 453 607 | -4.5% | 43.9% | -0.2 | -6.9% |
| REDUXIN FORTE | 172 731 | 2.1% | 9.8% | 0.9 | 760 907 325 | 7.0% | 11.2% | 1.2 | -6.9% |
| SALVISAR | 622 450 | 23.9% | 1.6% | 0.4 | 288 976 225 | 58.5% | 1.5% | 0.5 | -6.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 8 939 | -7.3% | 13.0% | -0.6 | 20 406 863 | -7.9% | 9.8% | -0.5 | -2.8% |
| BRAINMAX | 2 583 | 8.6% | 100.0% | 0 | 8 981 610 | 12.6% | 100.0% | 0 | 8.6% |
| GOLDLINE PLUS | 15 815 | -5.2% | 45.6% | -0.1 | 49 561 551 | -6.7% | 36.6% | 0 | -5.0% |
| MIGRENIUM | 7 329 | -6.2% | 0.3% | 0 | 2 584 375 | -6.5% | 0.5% | 0 | -0.9% |
| MODELAX-N | 22 790 | -5.8% | 17.3% | -0.4 | 12 700 013 | -7.1% | 12.8% | -0.6 | -3.7% |
| REDUXIN CAPS | 10 750 | -2.1% | 31.0% | 0.9 | 59 044 036 | -3.4% | 43.6% | 1.5 | -5.0% |
| REDUXIN FORTE | 3 554 | -10.8% | 10.2% | -0.7 | 16 253 551 | -16.0% | 12.0% | -1.4 | -5.0% |
| SALVISAR | 10 425 | -9.6% | 1.4% | -0.1 | 5 327 581 | -10.2% | 1.4% | -0.1 | -2.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 40 295 | -3.4% | 13.1% | 0.5 | 92 162 664 | -1.7% | 9.9% | 0.5 | -7.3% |
| BRAINMAX | 10 860 | -7.3% | 100.0% | 0 | 37 510 343 | -8.9% | 100.0% | 0 | -7.3% |
| GOLDLINE PLUS | 73 279 | 0.6% | 45.7% | 0.3 | 231 834 163 | -0.9% | 36.9% | -0.5 | 0.1% |
| MIGRENIUM | 34 787 | 1.5% | 0.4% | 0 | 12 297 924 | 1.5% | 0.5% | 0 | -2.5% |
| MODELAX-N | 107 892 | -5.5% | 17.9% | -0.8 | 60 208 046 | -1.4% | 13.3% | -0.4 | -1.0% |
| REDUXIN CAPS | 49 047 | -2.8% | 30.6% | -0.9 | 269 646 984 | -1.1% | 42.9% | -0.7 | 0.1% |
| REDUXIN FORTE | 16 876 | 7.1% | 10.5% | 0.7 | 78 994 217 | 10.6% | 12.6% | 1.2 | 0.1% |
| SALVISAR | 50 675 | -7.6% | 1.5% | -0.2 | 26 072 693 | -6.4% | 1.5% | -0.2 | 4.2% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs